Načítá se...
Implications of Immunotherapy in Hepatobiliary Tumors
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related death worldwide. Upon ineligibility for resection, liver transplantation, or locoregional therapies, sorafenib has been the only systemic treatment option of advanced HCC for more than a decade. Immunotherapy is an ev...
Uloženo v:
| Vydáno v: | Visc Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597927/ https://ncbi.nlm.nih.gov/pubmed/31312646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496755 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|